Creating enhanced, groundbreaking models for detecting drug or chemical toxicity is critical for bringing new products to market safely, quickly, and economically. Innovations in organotypic in vitro models have emerged as a key strategy to achieve the 3R principles (reduction, refinement, and replacement) of animal testing. Utilization of 3D tissue cultures provides innovative preclinical testing systems and viable alternatives to animal testing.
We foresee that 3D cultures will become instrumental in achieving the 3R goals in animal-based toxicity testing, playing a significant role in the Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) in the European Union.
At Life Technologies, we are committed to supporting your toxicity evaluation efforts by employing a range of complex models. These models span from straightforward, self-organized 3D cell cultures to more complex scaffold-based co-cultures that incorporate multiple cell types. This method ensures a comprehensive and reliable toxicity evaluation, contributing to safer and more efficient drug development processes.
Looking for customized in vitro 2D and 3D model based toxicity services? you can contact us, at email@example.com and we will be there to help you to meet your requirements.